235 Novel biparatopic TIM-3 antibody effectively blocks multiple inherent ligands and activates anti-tumor immunity
Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.235
Published Online: 2021-11-10
Published Print: 2021-11
Update policy: https://doi.org/10.1136/crossmarkpolicy
Mishima, Yuji
Nakajima, Kanto
Shiraishi, Mamoru
Matsumura, Haruka
Aramaki, Takahiko
Matsumoto, Noriko
Nakamura, Norihiro